CD34 and myelodysplastic syndrome: In conclusion, an antibody panel focused on the analysis of the myelomonocytic cell line and CD34+ cells was satisfactory for the differential diagnosis between reactive PB cytopenias and MDS with low BM blast counts and a normal karyotype.